Botulinum toxin treatment of extraocular muscles in rabbits results in increased myofiber remodeling

Investigative Ophthalmology and Visual Science

Volumn 46, Issue 11, 2005, Pages 4114-4120

  Ugalde, Irma ^a   Christiansen, Stephen P ^a   McLoon, Linda K ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN A; BROXURIDINE; DYSTROPHIN; MUSCLE RELAXANT AGENT; MYOD PROTEIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; EXTRAOCULAR MUSCLE; IMMUNOHISTOCHEMISTRY; MUSCLE CELL; NONHUMAN; PRIORITY JOURNAL; RABBIT; SATELLITE CELL; STRABISMUS; TREATMENT OUTCOME; ANIMAL; CELL NUCLEUS; CYTOLOGY; DNA REPLICATION; DRUG EFFECT; INTRAMUSCULAR DRUG ADMINISTRATION; METABOLISM; PHYSIOLOGY; REGENERATION; SKELETAL MUSCLE SATELLITE CELL;

ANIMALS; BOTULINUM TOXIN TYPE A; BROMODEOXYURIDINE; CELL NUCLEUS; DNA REPLICATION; INJECTIONS, INTRAMUSCULAR; MUSCLE FIBERS; MYOD PROTEIN; NEUROMUSCULAR AGENTS; OCULOMOTOR MUSCLES; RABBITS; REGENERATION; SATELLITE CELLS, SKELETAL MUSCLE;

EID: 33144472842     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: 10.1167/iovs.05-0549     Document Type: Article

References (50)

1. Scott AB, Kennedy RA, Stubbs HA. Botulinum toxin injection as a treatment for blepharospasm. Arch Ophthalmol. 1985;103:347-350.
2. Brin MF, Fahn S, Moskowitz D, et al. Localized injections of Botulinum toxin for treatment of focal dystonia and hemifacial spasm. Mov Disord. 1987;2:237-254.
3. Koman LA, Mooney JF, Smith B, Goodman A, Mulvaney T. Management of cerebral palsy with botulinum-A toxin: preliminary investigation. J Pediatr Orthop. 1993;13:489-495.
4. Scott AB. Botulinum toxin injection into extraocular muscles as an alternative to strabismus surgery. Ophthalmology. 1980;87:1044-1049.
5. Scott AB, Rosenbaum A, Collins CC. Pharmacologic weakening of extraocular muscles. Invest Ophthalmol. 1973;12:924-927.
6. Elston JS, Lee JP, Powell CM, Hogg C, Clark P. Treatment of strabismus in adults with botulinum toxin A. Br J Ophthalmol. 1985;69:718-724.
7. Holland RL, Brown MC. Nerve growth in botulinum toxin poisoned muscles. Neuroscience. 1981;6:1167-1179.
8. Angaut-Petit D, Molgo J, Comelia JX, Faille L, Tabti N. Terminal sprouting in mouse neuromuscular junctions poisoned with botulinum type A toxin: morphological and electrophysiological features. Neuroscience. 1990;37:799-808.
9. Holds JB, Alderson K, Fogg SG, Anderson RL. Motor nerve sprouting in human orbicularis muscle after botulinum A injection. Invest Ophthalmol Vis Sci. 1990;31:964-967.
10. De Paiva A, Meunier FA, Molgo J, Aoki KR, Dolly JO. Functional repair of motor endplates after botulinum neurotoxin type A poisoning: biphasic switch of synaptic activity between nerve sprouts and their parent terminals. Proc Natl Acad Sci USA. 1999; 96:3200-3205.
11. Tan EK, Jankovic J. Botulinum toxin A in patients with oromandibular dystonia: long-term follow-up. Neurology. 1999;53:2102-2107.
12. Brin MF. Dosing, administration, and a treatment algorithm for use of botulinum toxin A for adult-onset spasticity. Spasticity Study Group. Muscle Nerve Suppl. 1997;6:S208-220.
13. Defazio G, Abbruzzese G, Girlanda P, et al. Botulinum toxin A treatment for primary hemifacial spasm: a 10 year multicenter study. Arch Neurol. 2002;59:418-420.
14. Calace P, Coretese G, Piscopo R, et al. Treatment of blepharospasm with botulinum neurotoxin type A: long-term results. Eur J Ophthalmol. 2003;13:331-336.
15. Dimitrova DM, Shall MS, Goldberg SJ. Short-term effects of botulinum toxin on the lateral rectus muscle of the cat. Exp Brain Res. 2002;147:449-455.
16. Duchen LW. Changes in motor innervation and cholinesterase localization induced by botulinum toxin in skeletal muscle of the mouse: differences between fast and slow muscles. J Neurol Neurosurg Psychiat. 1970;33:40-54.
17. Hassan SM, Jennekens FGI, Veldman H. Botulinum toxin-induced myopathy in the rat. Brain. 1995;118:533-545.
18. Spencer RF, McNeer KW. Botulinum toxin paralysis of adult monkey extraocular muscle: structural alterations in orbital, singly innervated muscle fibers. Arch Ophthalmol. 1987;105:1703-1711.
19. Krancj BS, Sketelj J, D'Albis A, Erzen I. Long-term changes in myosin heavy chain composition after botulinum toxin A injection into rat medial rectus muscle. Invest Ophthalmol Vis Sci. 2001; 42:3158-3164.
20. Porter JD, Baker RS. Muscles of a different "color": the unusual properties of the extraocular muscles may predispose or protect them in neurogenic and myogenic disease. Neurology. 1996;46: 30-37.
21. McLoon LK, Wirtschafter JD. Continuous myonuclear addition to single extraocular myofibers of uninjured adult rabbits. Muscle Nerve. 2002;25:348-358.
22. McLoon LK, Wirtschafter JD. Activated satellite cells are present in uninjured extraocular muscles of mature mice. Trans Am Ophthalmol Soc. 2002;100:119-123.
23. McLoon LK, Wirtschafter JD. Activated satellite cells in extraocular muscles of normal adult monkeys and humans. Invest Ophthalmol Vis Sci. 2003;44:1927-1932.
24. McLoon LK, Rowe J, Wirtschafter JD, McCormick KM. Continuous myofiber remodeling in uninjured extraocular myofibers: myonuclear turnover and evidence for apoptosis. Muscle Nerve. 2004; 29:707-715.
25. Moreno-Lopez B, Pastor AM, De La Cruz RR, Delgado-Garcia JM. Dose-dependent, central effects of botulinum neurotoxin type A: a pilot study in the alert behaving cat. Neurology. 1997;48:456-464.
26. Dengis CA, Steinbach MJ, Kraft SP. Registered eye position: short- and long-term effects of botulinum toxin injected into eye muscle. Exp Brain Res. 1998;119:475-482.
27. Stahl JS, Averbuch-Heller L, Remler BF, Leigh RJ. Clinical evidence of extraocular muscle fiber-type specificity of botulinum toxin. Neurology. 1998;51:1093-1099.
28. Pamphlett R. Early terminal and nodal sprouting of motor axons after botulinum toxin. J Neurol Sci. 1989;92:181-192.
29. Pinter MJ, Van den Noven S, Muccio D, Wallace N. Axotomy-like changes in cat motoneuron electrical properties elicited by botulinum toxin depend on the complete elimination of neuromuscular transmission. J Neurosci. 1991;11:657-666.
30. Van Putten MJAM, Padberg M, Tavy DLJ. In vivo analysis of end plate noise of human extensor digitorum brevis muscle after intramuscularly injected botulinum toxin type A. Muscle Nerve. 2002;26:784-790.
31. Hawke TJ, Garry DJ. Myogenic satellite cells: physiology to molecular biology. J Appl Physiol. 2001;91:534-551.
32. Siegel SG, Patton B, English AW. Ciliary neurotrophic factor is required for motoneuron sprouting. Exp Neurol. 2000;166:205-212.
33. Rabinovsky ED, Gelir E, Gelir S, et al. Targeted expression of IGF-1 transgene to skeletal muscle accelerates muscle and motor neuron regeneration. FASEB J. 2003;17:53-55.
34. Yamaguchi A, Ishii H, Morita I, Oota I, Takeda H. mRNA expression of fibroblast growth factors and hepatocyte growth factor in rat plantaris muscle following denervation and compensatory overload. Pflugers Arch. 2004;448:539-546.
35. Fischer MD, Gorospe JR, Felder E, et al. Expression profiling reveals metabolic and structural components of extraocular muscles. Physiol Genomics. 2002;9:71-84.
36. Paul AC, Rosenthal N. Different modes of hypertrophy in skeletal muscle fibers. J Cell Biol. 2002;156:751-760.
37. Zhu X, McShea A, Harris PL, et al. Elevated expression of a regulator of the G2/M phase of the cell cycle, neuronal CIP-1-associated regulator of cyclin B, in Alzheimer's disease. J Neurosci Res. 2004;75:698-703.
38. Olguin HC, Olwin BB. Pax-7 up-regulation inhibits myogenesis and cell cycle progression in satellite cells: a potential mechanism for self-renewal. Dev Biol. 2004;275:375-388.
39. Bonner PH, Friedli AF, Baker RS. Botulinum A toxin stimulates neurite branching in nerve-muscle cocultures. Brain Res Dev Brain Res. 1994;79:39-46.
40. Hyatt JP, Roy RR, Baldwin KM, Edgerton VR. Nerve activity-independent regulation of skeletal muscle atrophy: role of MyoD and myogenin in satellite cells and myonuclei. Am J Physiol. 2003;285: C161-C173.
41. Ishido M, Kami K, Masuhara M. In vivo expression patterns of MyoD, p21 and Rb proteins in myonuclei and satellite cells of denervated rat skeletal muscle. Am J Physiol. 2004;287:C484-C493.
42. Witzemann V, Sakmann B. Differential regulation of MyoD and myogenin mRNA levels by nerve induced muscle activity. FEBS Lett. 1991;282:259-264.
43. Lowe DA, Lund T, Alway SE. Hypertrophy-stimulated myogenic regulatory factor mRNA increases are attenuated in fast muscle of aged quails. Am J Physiol. 1998;275:C155-C162.
44. Gallegly JC, Turesky NA, Strotman BA, Gurley CM, Peterson CA, Dupont-Versteegden EE. Satellite cell regulation of muscle mass is altered at old age. J Appl Physiol. 2004;97:1082-1090.
45. Ishido M, Kami K, Masuhara M. Localization of MyoD, myogenin and cell regulatory factors in hypertrophying rat skeletal muscles. Acta Physiol Scand. 2004;180:281-289.
46. Lowe DA, Alway SE. Stretch-induced myogenin, MyoD, and MRF4 expression and acute hypertrophy in quail slow-tonic muscle are not dependent upon satellite cell proliferation. Cell Tissue Res. 1999;296:531-539.
47. Chen CM, Stott NS, Smith HK. Effects of botulinum toxin A injection and exercise on the growth of juvenile rat gastrocnemius muscle. J Appl Physiol. 2002;93:1437-1447.
48. Porter JD, Strebeck S, Capra NF. Botulinum-induced changes in monkey eyelid muscle. Comparison with changes seen in extraocular muscle. Arch Ophthalmol. 1991;109:396-404.
49. Inagi K, Connor NP, Schultz E, Ford CN, Cook CH, Heisey DM. Muscle fiber-type changes induced by botulinum toxin injection in the rat larynx. Otolaryngol Head Neck Surg. 1999;120:876-883.
50. Yoshimura K, Harii K. A regenerative change during muscle adaptation to denervation in rats. J Surg Res. 1999;81:139-146.